Background: Health reform programs like the patient-centered medical home are intended to improve the triple aim. Previous studies on patient-centered medical homes have shown mixed effects, but high value elements (HVEs) are expected to improve the triple aim.
P atients with chronic illness account for over 80% of health care expenditures, 1 but outcomes for patients with chronic illness continue to be poor. For instance, both ageadjusted and sex-adjusted mortality rates for diabetes or chronic kidney disease, and the individual burden of living with chronic illness continue to increase. 2, 3 These patients need comprehensive, coordinated, patient-centered care 3, 4 ; however, primary care clinics are incented to provide episodic, fee-for-service care. This disconnect-the need for continuous care in a system promoting episodic care-is expected to reduce patient experience of care.
Chronic illness control requires a partnership between patients and clinical teams. Behavior, lifestyle, and social determinants of health, such as race and socioeconomic status, affect a patient's ability to gain access to care and manage their chronic illness. 5 The possible complexity, risk and benefit ratios, and burden of medical treatment require that patient preferences and values be elicited and treatment decisions be shared by patients and providers. 6 Better chronic illness outcomes, including improved health, reduced costs, and improved satisfaction, come when patients receive significant self-monitoring support, proactive planning, and patient-centered education. 7 Measurement of these factors in primary care includes a number of patient reported outcomes, including patient's experience of care. 8 The most common validated survey for patient experience of care is the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey; for primary care, a clinician and group (CG)-CAHPS survey asks patients to report these experiences across 11 composite categories. Historically and in general, primary care has a wide variability in CG-CAHPS scores. 9 Health reform is intended to address these issues by changing the way care is supported through incentives, infrastructure support, and technical assistance to improve the triple aim of health care: improving patient experience of care, health of populations, and reducing cost. In primary care, the patient-centered medical home (PCMH) is the most common reform model, having >10,000 primary care clinics accredited; to achieve certification, they must show that they performed certain services for their patients, including improved access, care management, population management, and quality improvement (QI). 10 Although the PCMH model is 1 attempt to improve care for patients with chronic conditions in the United States, other models such as the Innovative Care for Chronic Conditions, created by the World Health Organization in 2002, have similar goals. This model overlaps with relevant PCMH principles, such as building integrated health care to coordinate across different settings, using health care personnel effectively to provide team-based care, and placing patients at the center of care. 11 Although intended to improve the triple aim, health reform efforts to date have had mixed success, especially in patient experience of care and cost. Although efforts at Geisinger Health System, GroupHealth, and Intermountain Healthcare have been successful, [12] [13] [14] other models, such as the National Demonstration Project, the Southeast Pennsylvania PCMH initiative, and others have not shown improvements. 15, 16 Similarly, in 1 study, patient experience of care survey results demonstrated a positive association between PCMH status and improved access to care, but not with other domains such as experience with office staff or follow-up on test results. 17 Finally, a 2012 evaluation of 11 Medicare coordinated care demonstrations identified 6 key features of programs successfully decreasing hospital admissions (care coordinators having face-to-face contact with patients, care coordinators managing transitions of care, using patient education to affect behavior change, care coordinators communicating often with physicians, medication management, and physician engagement). 18 We initiated the Transforming Outcomes for Patients Through Medical Home Evaluation and reDesign (TOPMED) trial to better understand how to replicate the common components of trials that seem to improve patient outcomes and support transformation more effectively in smaller systems and individual clinics. Intervention clinics received focused encouragement, including being asked to work on high value elements (HVEs) which have been shown to improve patient outcomes and costs in the previous trials. Although the derivation of these HVEs is described elsewhere, 19 we largely determined these elements through a literature review and focus groups with experts and patients to find measures most likely to improve patient experience and reduce poor outcomes that were related to the broad PCMH attributes of accountability, access, coordination and integration, comprehensive care, continuity, and patient and family experience. For instance, in Oregon's PCMH model the care coordination measure is "Assigns individual responsibility for care coordination and tells each patient or family the name of the team member responsible for coordinating his or her care," whereas the HVE for care coordination is "Care coordination outreach reaches 25% of high-risk patients." One of the outcomes for this trial that other similar studies have not analyzed explicitly through a focus on specific components of PCMH standards and HVEs was patient experience of care, measured by the CG-CAHPS survey with specific questions for PCMHs added.
The purpose of this paper is to investigate whether focusing on HVEs will improve patients' experience with care, especially in areas related to HVEs. We hypothesized that both intervention and control clinics will see improvements in patient experience because both received QI encouragement; however, we predict that there will be a greater improvement in the intervention clinics due to their focus on HVEs.
METHODS

Overview
We completed a pragmatic cluster-randomized controlled trial in primary care clinics across the state of Oregon. The Oregon Health and Science University's Institutional Review Board approved this study. The trial protocol, created and reported according to CONSORT guidelines (Appendix 1, Supplemental Digital Content 1, http://links. lww.com/MLR/B178), is published elsewhere 20 ; briefly, all practices were stratified into matched pairs, then randomized by computer into 2 groups. All practices received IT-based milestone reporting, financial incentives on the basis of selfselected QI goals, and QI guidance from a practice facilitator (PF). PFs have been demonstrated to provide a framework for practices to identify leadership, build relationships internally and externally, and monitor and evaluate QI progress and are associated with completing more QI projects. 21, 22 The TOPMED PF met with all practices monthly to identify areas for improvement and monitor progress on previously set goals. Intervention clinics were directed to select their QI goals from a list of 12 HVEs, which our team identified from the literature and stakeholder and patient focus groups as likely to reduce cost and utilization and improve patient outcomes. Control clinics selected goals related to PCMH measures. Each arm received an equal amount of touches from the PF and on an average each clinic made 7.75 QI goals over the year. The current paper will discuss changes in patient experience of care from before and after the trial. Patient experience had been demonstrated to be crucial in driving system transformation and is associated with improvements in patient engagement and adherence and clinical processes and outcomes. 23 HVEs related directly to CAHPS composites and working on them may improve those respective composites. For instance, the HVEs of advance directive utilization, education and self-management resources, and care plan utilization may influence the CAHPS composite of providers support you in taking care of your own health.
Setting
The study took place in 8 primary care clinics that were engaged in PCMH health reform located in 5 different counties in Oregon; over 500 practices in Oregon and 10,000 nationwide are engaged in PCMH-related redesign. The practices were diverse in terms of size (3-20 providers), location (urban vs. rural), and population. Implementation of the TOPMED trial occurred between May 2013 and May 2014.
Sampling, Recruitment, and Administration
The practices were recruited by the Oregon Rural Practice-based Research Network. Eligibility included an implemented electronic health record, willingness to participate in QI efforts, and a practice panel that contained adult patients. Once enrolled, practices were stratified by size, location, and ownership (health system vs. independent), and paired clinics were randomized by a computer to either intervention or control.
Patients selected to receive presurvey or postsurveys had visited the respective practice within the last year, spoke English, and were aged 18 years or above. Electronic health record data were queried to randomly select 100 patients per clinic per time period (1600 total surveys sent); we estimated 80% power to detect a 10% difference with base score of 50% and a 50% response rate. Because of the differences in clinic population, patients determined by a modified Charlson Comorbidity Risk score to be high risk (Z2 chronic illnesses) were oversampled at 50% of total sample, whereas average-risk patients (0-1 illnesses) constituted the remaining 50%.
Pretrial survey data were collected between May 2013 and September 2013, and posttrial data were collected between May 2014 and September 2014. Surveys were initially mailed in May, and phone call reminders were made in mid-June to encourage additional responses. Samples for presurveys and postsurveys were different. In August, surveys were remailed to participants who had not responded. Included with the surveys was an information sheet, which invited them to participate and explained the study, and an optional sheet to complete to be entered into a gift card drawing. Patients were excluded if they died, were too ill, did not receive care from the provider on their survey within the last year, did not speak English, or their survey was returned undeliverable.
Measurement of Patient Experience
Patient experience of care was measured with the validated 2007 CG-CAHPS, which asks patients to rate their experiences with doctors and staff. It is a commonly used patient survey that has been tested for reliability, construct validity, and criterion validity at a practice level and patient level. 24, 25 It contains 44 questions about experience of care, grouped into 11 composite scores, with additional demographic questions. These composites, such as getting care quickly, courteous office staff, and getting needed care, have been found to be associated with global ratings of patient satisfaction with health care. 26 The composites each have between 1 and 6 component questions, which are mainly 4point ordinal ratings (never to always and poor to excellent) with some yes/no questions, and one 0-10 point overall rating of the provider.
Statistical Analysis
The main outcome of interest was the difference between control and intervention clinics in the change between prestudy and poststudy patient satisfaction, or the "difference in differences." Patient satisfaction was calculated as the percentage of all responses across a composite that fell in the best (or top-box) category, for example rating of 4 on a 4-point scale. For each of the 11 composite scores, we fit a population-averaged linear probability model with response as the unit of analysis and a generalized estimating equation approach to account for similarity between responses from the same person. Because randomization occurred at the clinic level, we could not simultaneously model intervention and use generalized estimating equation for correlation between responses from the same clinic; instead, we fit clinic and pre-post indicator variables along with their interactions and used them to calculate overall intervention differences in differences adjusted for age, minority, and risk status as defined by the modified Charlson score. The statistician performing analyses was blinded to intervention and control groups.
Analysis was performed to see if achieving certain HVEs was associated with 5 related composite scores. Correlations between these HVEs over time and change in these 5 composite scores were calculated. We consider P < 0.10 and 0.05 as marginally and highly significant to acknowledge the large intracluster and between-time variation, which reduced our power across several composites. In addition, other studies utilizing patient surveys have included both these levels in their results and discussions. 27, 28 Furthermore, absolute value percentage changes >5% and 10%, representing a number needed to treat from 1 in 10 to 1 in 20, are considered moderate and major trends, respectively.
RESULTS
A total of 1597 CAHPS surveys were sent, 795 (49.8%) for the pretrial and 802 (50.2%) for the posttrial; 178 surveys were excluded (11.1%), and detailed statistics are found in Figure 1 . Our analysis included 163 (45.0%) eligible pretrial surveys for the intervention group and 170 (45.6%) for the control group; there were 178 (52.0%) eligible posttrial surveys for the intervention group and 175 (51.2%) in the control. Respondent and nonrespondent bias analysis (Appendix 2, Supplemental Digital Content 2, http:// links.lww.com/MLR/B179) shows that a higher percent of low-risk patients responded in the pretrial, and a higher percentage of high-risk patients responded in the posttrial, which also affected age distribution. The survey analysis used interaction terms to account for these effects. Table 1 shows that there were no significant differences among respondents in the pre-post periods in either arm for age, sex, self-rating of physical and emotional health, or who helped to fill out the survey (average difference, 0.3%). The preperiod had fewer high-risk patients in the control group (43.7%) than the intervention (49.1%), but both arms were evenly represented during the postperiod with 58% high-risk respondents in both groups. Table 2 shows the differences between clinics and their matching criteria: location, size, and relative percentages of high-risk patients; the matching reduced cluster differences but substantial differences remained. Table 3 and Figure 2 present the adjusted CAHPS results that account for the demographic and risk differences between respondents. The adjusted patient experience of care results show that pretrial values are mostly similar between the intervention and control groups. Differences between groups include the control performing better in patient's rating of the provider (70.6% intervention vs. 80.4% control) and providers support you in taking care of your own health (42.4% vs. 50.8%), whereas the intervention performed better in getting timely appointments, care, and information (57.9% vs. 50.4%) and access to care (42.1% vs. 56.1%). None of the differences were statistically significant at the P < 0.10 level.
The results for CAHPS scores are mixed. The difference-in-difference results show an average difference of 2.8% with the intervention performing better than the control, and 3 of the 11 composites have major differences between the intervention and control. Over time the intervention performed better than the control in follow-up on test results with a slight 0.8% increase, and the control decreased significantly by 12.8% (difference in difference 13.5%, P = 0.091). Similarly for patient's rating of the provider, the intervention had a small 1.5% increase, whereas the control decreased significantly by 10.3% (11.8%, P = 0.091). However, the control was better in access to care with the intervention decreasing significantly by 13.2%, and the control showing a small 0.6% increase (À 13.2%, P = 0.093). In addition, there was a moderate difference favoring the intervention for providers support you in taking care of your own health with the intervention increasing by 2.9% and the control decreasing by 4.5% (7.4%, P = 0.27).
For pre-post changes, the intervention and control performed similarly for 3 composites, which might be explained by contemporaneous trends. For getting timely appointments, care, and information, the intervention had a moderate decrease of 7.9%, and the control had a major decrease of 11.3% (3.3%, P = 0.55). In addition, the intervention and control had moderate decreases, 5.3% and 6.2%, respectively, for how well providers (or doctors) communicated with patients (À 5.3%, P = 0.90). Both intervention and control increased moderately, 5.3% and 6.6%, respectively, for providers pay attention to your mental or emotional health (1.3%, P = 0.838).
In the study, HVEs are intended to help clinics improve cost and utilization; patient experience of care elements more related to these outcomes might improve more in the intervention clinic. Our preanalysis grouping of the patient experience of care measures identified providers support you in taking care of your own health (D-I-D+7.4%); providers pay attention to your mental or emotional health (+1.3%); and how well providers (or doctors) communicate with patients (+0.9%) as highly related to HVEs, and follow-up on test results (+13.5%); attention to care from other providers (À 4.4%); and providers discuss medication decisions (+3.9%); as somewhat related. Of these 6, 2 demonstrated strong improvement, and 2 showed improvement for intervention versus control, providing moderate support for the hypothesis. However, none of these differences were statistically significant, and correlations between number of HVEs obtained and patient experience of care were nonsignificant.
CONCLUSIONS
Our cluster-randomized controlled trial compared the outcomes of patients' experience of care when their primary care practices were incented to achieve HVEs (intervention) versus standard QIs (control), showed that we were partially successful in that the difference in difference for patient experience was more positive (and sometimes declined less) in intervention clinics. Two composites improved marginally significantly more (P < 0.10) in the intervention than the control, whereas 1 composite improved more in the control. However, there was an overall reduction in patient experience in several categories, so the intervention might be described as worsening less in these composites versus control.
An overall decline in patient experience of care may have several sources, including contemporaneous factors. First, during the time period of the study, Medicaid expansion occurred in Oregon as did a major failure in Oregon's Health Insurance Exchange, leading to significant frustrations and a relative decrease in access across the state. A contemporaneous survey for CAHPS showed a decrease in access scores for primary care clinics in Oregon from 85% to 50%, 29 which is similar to the postperiod's 49.5% for intervention and 56.8% for controls. In addition, research in New York, comparing CAHPS results from PCMH-recognized clinics and non-PCMH clinics, showed that access to care scored lower in PCMH clinics than non-PCMH clinics. 30 It is feasible that PCMH recognition might require additional clinical resources, thereby decreasing patients' perceived access to care. Finally, the CAHPS survey focuses heavily on providers, rather than the care team, thus the team-based aspects of the HVEs and QI efforts may have worsened scores inadvertently. Working on HVEs for QI may have had positive and negative impacts on patient experience. For instance, providers support you in taking care of your own health relates to the education and self-management resources HVE, and patients responded more positively in the intervention. Contrarily, some of the HVEs and some of the CAHPS composites do not have a strong theoretical relationship, including Clinical Information Exchange (HVE) and how well providers (or doctors) communicated with patients (CAHPS); many patients may not have a better experience with these HVEs improving.
Limitations of this study include the low number of clusters, selection bias, inability to adjust for respondent bias and mean reversion, and the lack of strong correlation of the CAHPS survey with the intent of the study. The low numbers of clusters means that individual cluster variation might drive outcomes more than the intervention; for instance, if a single cluster transforms its efforts, it could tip results toward intervention or control with no effect from the study itself. We adjusted for this variation conservatively, leading to large differences with marginal P-values. Both selection and respondent bias also were evident; although, we created a randomized stratified sample of patients, those motivated to respond in the preperiods and postperiods were different. Although we statistically attempt to account for these differences, some bias may remain. 31 We also show that the majority of composites were better in the intervention than control over time, but the actual number of HVEs achieved did not directly impact the patient experience score.
In the setting of decreased satisfaction with care, we saw a more positive response from patients in their experience of care when clinics were encouraged to achieve HVEs, such as intensive care planning, care coordination, and selfmanagement support. Other PCMH trials have shown mixed effect on patient experience outcomes, but the TOPMED trial demonstrated that focusing on HVEs can improve patient experience or at least act as a protective factor against outside influences. The TOPMED design, including HVEs, may help inform future practice transformation efforts to present specific transformation options in conjunction with practice facilitation if improved patient experience is desired.
